Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
Adequate vaccine effectiveness response
Ask a
question
Favorite
WHO have created a definition for adequate COVID-19 vaccine effectiveness,3 in which the vaccine effectiveness against symptomatic infections should be at least 70% with a lower 95% CI of at least 50%, and the vaccine effectiveness against hospitalisations or mortality should be at least 90% with a lower 95% CI of at least 70%. In this systematic review, we assessed results in terms of statistically significant reductions in vaccine effectiveness from baseline and meeting these WHO criteria.
Copyright and License information: ©2023 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
